CrushSCI.com
Journal Selection & Manuscript Polishing Services
JOURNAL OF DERMATOLOGICAL TREATMENT journal cover Medicine
Back to journal directory

Review Cycle Records

JOURNAL OF DERMATOLOGICAL TREATMENT

Taylor & Francis SCIE OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q1
100.4Average days
65Median days
2Fastest days
242Longest days
1932025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

65 days

Clinical predictors of early treatment response across systemic therapies in psoriasis: a prospective cohort study

AuthorsDidaer Muheyati; Yuxiong Jiang; Zhenquan Xuan; Siqi Li; Lian Cui; Rui Ma; Yukun Wang; Yuye Wang; Tong Liu; Yuanwenke Zhang; Qian Yu; Xinling Bi; Yuling Shi

Affiliations1. Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine; 2. Institute of Psoriasis, Tongji University School of Medicine; 3. Psoriasis Clinical Research Center, Tongji University; 4. Department of Dermatology, The First Affiliated Hospital of Naval Medical University

Source PDF DOI Publisher page
60 days

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review

AuthorsApril W. Armstrong; Bruce E. Strober; Clive M. Liu; Jennifer C. Cather; Joseph F. Merola; Mark G. Lebwohl

Affiliations1. Division of Dermatology, University of California Los Angeles; 2. Central Connecticut Dermatology Research; 3. Yale University; 4. Bellevue Dermatology; 5. Mindful Dermatology and Modern Research Associates; 6. Department of Dermatology and Division of Rheumatology, UT Southwestern Medical Center; 7. Icahn School of Medicine at Mount Sinai

Source PDF DOI Publisher page
58 days

Patient preferences for prurigo nodularis treatment: a discrete choice experiment

AuthorsAnthony Bewley; Sarina Elmariah; Pablo Arija; Katrin Jack; Marco Boeri; Rajesh Rout; Ramkumar Subramanian; Jorge Puelles

Affiliations1. Barts Health NHS Trust and Queen Mary University; 2. University of California San Francisco; 3. OPEN Health HEOR & Market Access; 4. Global Product Strategy; 5. Medical Affairs EMEAC; 6. Global Health Economics and Outcomes Research

Source PDF DOI Publisher page
87 days

Patients’ and clinicians’ perspectives on telemedicine to monitor patients on systemic treatment for psoriasis or atopic dermatitis - a mixed methods study

AuthorsNikki F. T. Henckens; Marta E. Pawlak; Sophie A. C. Wanten; Ying C. Weng; Ilse v. Ee; Bernd W. M. Arents; Leonard Witkamp; Marjolein S. de Bruin-Weller; Ewout M. Baerveldt; Marieke M. B. Seyger; Elke M. G. J. de Jong; Wynanda A. van Enst; Juul M. P. A. van den Reek

Affiliations1. Department of Dermatology, Radboud University Medical Center; 2. Dutch Society for Dermatology and Venereology; 3. Dutch National Psoriasis Patient Association; 4. Dutch Association for People with Atopic Dermatitis; 5. Ksyos Health Management Research; 6. Department of Dermatology and Allergology, University Medical Center Utrecht; 7. Depts. Dermatology, IJsselland Medical Hospital; 8. Department of Dermatology, St. Antonius Hospital, Nieuwegein/Utrecht

Source PDF DOI Publisher page
15 days

Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL

AuthorsRaj Chovatiya; Matthew Zirwas; Melinda J. Gooderham; Christine Bangert; Rodney Sinclair; Marjolein de Bruin-Weller; Stephan Weidinger; Carmen Tsang; Caitriona McCarthy; Andrew Selfridge; Pinaki Biswas; Herwig Koppensteiner; Claire Feeney; Sara Ramaker; Gary Chan

Affiliations1. Chicago Medical School, Rosalind Franklin University of Medicine and Science; 2. Center for Medical Dermatology + Immunology Research; 3. DOCS Dermatology; 4. Probity Medical Research; 5. Ohio University; 6. SKiN Centre for Dermatology; 7. Queen’s University; 8. Medical University of Vienna; 9. Sinclair Dermatology; 10. National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht; 11. University Hospital Schleswig-Holstein; 12. Pfizer Inc; 13. Pfizer Healthcare Ireland; 14. Pfizer Corporation Austria GmbH

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.